tiprankstipranks
Genertec Universal Medical Group Company Limited (UMTAF)
OTHER OTC:UMTAF

Genertec Universal Medical Group Company (UMTAF) Income Statement

8 Followers

Genertec Universal Medical Group Company Income Statement

Last quarter (Q2 2022), Genertec Universal Medical Group Company's total revenue was ¥―, a decrease of ― from the same quarter last year. In Q2, Genertec Universal Medical Group Company's net income was ¥―. See Genertec Universal Medical Group Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-¥ 9.91B¥ 8.52B¥ 6.82B¥ 4.30B¥ 3.42B
Cost of Revenue
-¥ 5.71B¥ 4.97B¥ 3.64B¥ 1.71B¥ 1.24B
Gross Profit
-¥ 4.20B¥ 3.55B¥ 3.18B¥ 2.59B¥ 2.17B
Operating Expense
-¥ 990.25M¥ 859.91M¥ 755.73M¥ 596.15M¥ 500.43M
Operating Income
-¥ 3.21B¥ 2.69B¥ 2.42B¥ 2.00B¥ 1.67B
Net Non Operating Interest Income Expense
-¥ 27.56M¥ 13.00M¥ 79.27M¥ 44.13M¥ 34.23M
Other Income Expense
------
Pretax Income
-¥ 2.69B¥ 2.37B¥ 2.21B¥ 1.86B¥ 1.58B
Tax Provision
-¥ 661.34M¥ 551.10M¥ 577.47M¥ 508.38M¥ 427.78M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-¥ 1.84B¥ 1.65B¥ 1.49B¥ 1.35B¥ 1.15B
Basic EPS
-¥ 0.99¥ 0.96¥ 0.87¥ 0.79¥ 0.67
Diluted EPS
-¥ 0.91¥ 0.96¥ 0.87¥ 0.79¥ 0.67
Basic Average Shares
-¥ 1.86B¥ 1.72B¥ 1.72B¥ 1.72B¥ 1.72B
Diluted Average Shares
-¥ 2.04B¥ 1.72B¥ 1.72B¥ 1.72B¥ 1.72B
Dividend Per Share
-¥ 0.26¥ 0.00¥ 0.24¥ 0.20¥ 0.15
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-¥ 6.71B¥ 5.83B¥ 4.39B¥ 2.30B¥ 1.75B
Net Income From Continuing And Discontinued Operation
-¥ 1.95B¥ 1.75B¥ 1.59B¥ 1.35B¥ 1.15B
Normalized Income
-¥ 2.18B¥ 1.93B¥ 1.74B¥ 1.41B¥ 1.23B
Interest Expense
-¥ 29.13M¥ 30.56M¥ 11.98M¥ 419.00K¥ 122.00K
EBIT
-¥ 2.72B¥ 2.40B¥ 2.22B¥ 1.86B¥ 1.58B
EBITDA
-¥ 3.04B¥ 2.67B¥ 2.36B¥ 1.89B¥ 1.60B
Currency in CNY

Genertec Universal Medical Group Company Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis